Document Detail

Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas.
MedLine Citation:
PMID:  1612204     Owner:  NLM     Status:  MEDLINE    
Long-term survival of dog islet allografts implanted in diabetic pancreatectomized dogs was achieved by islet encapsulation inside cylindrical chambers fabricated from permselective acrylic membranes (nominal M(r) exclusion of 50,000-80,000). Dog islets were isolated from the pancreases of outbred mongrel dogs by collagenase digestion. Chambers containing mean +/- SE 316 +/- 63K islet equivalents (mean islet volume, 558 +/- 111 mm3, purity 90-95%) were peritoneally implanted into six totally pancreatectomized dogs. The dogs were monitored for glycemic control by fasting and postprandial blood glucose determinations, and responses to both intravenous glucose (intravenous glucose tolerance test 0.5 g/kg) and oral glucose (oral glucose tolerance test 1 g/kg). All of the dogs required appreciably lower dosages of exogenous insulin therapy for control of fasting blood glucose levels, with the mean daily insulin dose dropping from 38 +/- 7 to 5 +/- 1 U/day during the 1st wk. Three recipients required no insulin for greater than 82, greater than 68, and 51 days. Intravenous glucose tolerance test K values (decline in glucose levels, %/min) at 1 and 2 mo postimplantation were 2.7 +/- 0.4 and 2.0 +/- 0.5, respectively compared with 3.5 +/- 0.5 before pancreatectomy. The glucose values during oral glucose tolerance tests at 2 wk, although returning to less than 125 mg/dl (less than 7.0 mM) by 2 h, exceeded the normal range, with peak values of 174 to 202 mg/dl (9.7 to 11.3 mM). These preliminary results are encouraging, and represent an important step in determining the feasibility of using this type of diffusion-based hybrid artificial pancreas as treatment for diabetes mellitus in humans.
R P Lanza; K M Borland; P Lodge; M Carretta; S J Sullivan; T E Muller; B A Solomon; T Maki; A P Monaco; W L Chick
Related Documents :
20384904 - Variation in characteristics of islets of langerhans in insulin-resistant, diabetic and...
10972194 - Effect of jindangwon on streptozotocin-induced diabetes.
1737834 - Feedback inhibition of insulin gene expression by insulin.
12114824 - Insulin and glucagon mrna expression and prohormone convertase immunoreactivity in norm...
2201274 - Effect of glucose in mice after acute experimental poisoning with arsenic trioxide (as2...
18253704 - Evaluation of serum selenium levels in turkish women with gestational diabetes mellitus...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes     Volume:  41     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  1992 Jul 
Date Detail:
Created Date:  1992-07-30     Completed Date:  1992-07-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  886-9     Citation Subset:  AIM; IM    
BioHybrid Technologies, Inc., Shrewsbury, MA 01545.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / metabolism
Diabetes Mellitus, Experimental / drug therapy,  surgery*
Glucose Tolerance Test
Insulin / therapeutic use
Islets of Langerhans Transplantation* / methods,  physiology
Transplantation, Homologous
Reg. No./Substance:
0/Blood Glucose; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before...
Next Document:  Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cel...